All In Biotech

Drug Trial Radar · NCT00000912

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

A Phase II, Randomized Trial of Amprenavir as Part of Dual Protease Inhibitor Regimens (Placebo-Controlled) in Combination With Abacavir, Efavirenz, and Adefovir Dipivoxil Versus Amprenavir Alone in HIV-Infected Subjects With Prior Exposure to Approved Protease Inhibitors and Loss of Virologic Suppression as Reflected by a Plasma HIV-1 RNA Concentration >= 1,000 Copies/ml

Last checked: Nov 19, 2026Latest source record: Oct 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

475

Actual

Start

Not stated

Primary completion

Not stated

Study completion May 2000

Sponsor

Sponsor type
NIH
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare 4 different combinations of anti-HIV drugs and to determine the number of people whose HIV blood levels decrease to 200 copies/ml or less while on the treatment. This study evaluates the safety of these drug combinations, which include an experimental protease inhibitor (PI), amprenavir. Despite the success that many patients have had with PI treatment regimens, there is still a possibility that patients receiving PIs may continue to have high HIV blood levels. Because of this possibility, alternative drug combinations containing PIs are being studied. It appears that amprenavir, when taken with 3 or 4 other anti-HIV drugs, may be effective in patients with prior PI treatment experience.

Conditions

  • HIV Infections

Interventions

  • Indinavir sulfateDrug

  • Abacavir sulfateDrug

  • AmprenavirDrug

  • Nelfinavir mesylateDrug

  • EfavirenzDrug

  • LevocarnitineDrug

  • Adefovir dipivoxilDrug

  • SaquinavirDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

45 sites in 2 countries. Site status is shown where the registry gives one.

  • Univ of Southern California / LA County USC Med Ctr

    Los Angeles, California

  • USC Univ Hosp & Ambulatory Hlth Care Ctr / USC Med Ctr

    Los Angeles, California

  • UCLA CARE Ctr

    Los Angeles, California

  • Willow Clinic

    Menlo Park, California

  • Univ of California / San Diego Treatment Ctr

    San Diego, California

  • San Francisco AIDS Clinic / San Francisco Gen Hosp

    San Francisco, California

  • San Francisco Gen Hosp

    San Francisco, California

  • Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium

    San Jose, California

  • San Mateo AIDS Program / Stanford Univ

    Stanford, California

  • Stanford Univ Med Ctr

    Stanford, California

  • Univ of Colorado Health Sciences Ctr

    Denver, Colorado

  • Howard Univ

    Washington D.C., District of Columbia

  • Univ of Miami School of Medicine

    Miami, Florida

  • Emory Univ

    Atlanta, Georgia

  • Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr

    Atlanta, Georgia

  • Queens Med Ctr

    Honolulu, Hawaii

  • Univ of Hawaii

    Honolulu, Hawaii

  • Tripler Army Med Ctr

    Tripler AMC, Hawaii

  • Northwestern Univ Med School

    Chicago, Illinois

  • Cook County Hosp

    Chicago, Illinois

  • Rush Presbyterian - Saint Luke's Med Ctr

    Chicago, Illinois

  • Charity Hosp / Tulane Univ Med School

    New Orleans, Louisiana

  • Tulane Univ School of Medicine

    New Orleans, Louisiana

  • Johns Hopkins Hosp

    Baltimore, Maryland

  • Harvard (Massachusetts Gen Hosp)

    Boston, Massachusetts

  • Boston Med Ctr

    Boston, Massachusetts

  • Univ of Minnesota

    Minneapolis, Minnesota

  • St Louis Regional Hosp / St Louis Regional Med Ctr

    St Louis, Missouri

  • SUNY / Erie County Med Ctr at Buffalo

    Buffalo, New York

  • Bellevue Hosp / New York Univ Med Ctr

    New York, New York

  • Chelsea Ctr

    New York, New York

  • Cornell Univ Med Ctr

    New York, New York

  • Mem Sloan - Kettering Cancer Ctr

    New York, New York

  • Mount Sinai Med Ctr

    New York, New York

  • Univ of Rochester Medical Center

    Rochester, New York

  • Duke Univ Med Ctr

    Durham, North Carolina

  • Moses H Cone Memorial Hosp

    Greensboro, North Carolina

  • Univ of Cincinnati

    Cincinnati, Ohio

  • Ohio State Univ Hosp Clinic

    Columbus, Ohio

  • Milton S Hershey Med Ctr

    Hershey, Pennsylvania

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.